Clover Health Investments Corp. (NASDAQ:CLOV)
Five-Star Plans Could Strengthen an Already Growing Membership Base
Clover Health Investments, Corp. (NASDAQ: CLOV) announced on October 8 that its Medicare Advantage PPO plans received five stars for 2027, while its HMO plan earned 4.5 stars. The company reported first-half membership growth of approximately 48% to more than 157,000, with about 98% enrolled in PPO plans. It says the five-star PPO plans can enroll beneficiaries year-round.
That alignment between highly rated plans and the membership base supports the bullish thesis. Broader enrollment opportunities could complement existing growth, while quality-related payment benefits could improve the resources available for competitive coverage. The ratings affect payment year 2028.
An important qualification is that CMS excluded 20 measures following a court decision that remains on appeal. The company disclosed that including those measures would have produced a 4.5-star PPO rating.
Investors should therefore distinguish the five-star enrollment advantage from the broader value of strong quality performance. The next financial test is whether membership growth produces attractive margins after medical and acquisition costs. Rapid expansion adds value when the economics of the additional members remain sound.
YOU MUST READ THIS: Top 10 Healthcare Stocks Under $10 to Watch Now
Disclosure: No material interests to disclose. This article was originally published on BioTech HealthX.
